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Induced Pluripotent Stem Cells (iPSC) are capable of extensive self-renewal while retaining the ability to 
differentiate into virtually all cell types of the body. These cells are the subject of much research and 
development activity aimed at the development of cell-based tools, which may speed drug discovery, and cell-
based medical therapies that are being developed to address unmet medical needs. However, development of 
these therapies is hampered by manufacturing bottlenecks including production scale up to meet the anticipated 
demand. PBS Biotech, Inc. has developed a single use bioreactor with an innovative Vertical-Wheel™ design 
that promotes more homogenous and gentle particle suspension, under lower hydrodynamic shear environment 
than traditional bioreactor vessel design. Vertical-Wheel bioreactors are available from lab-scale vessels (PBS 
MINI) to larger production units (up to 500L). This study describes the culture of human iPSCs on microcarriers 
under xeno-free conditions using Vertical-Wheel bioreactors. Human iPSCs were cultured on microcarriers to 
provide surface for cell attachment using the chemically defined Essential 8 culture medium, a xeno-free, 
feeder-free culture medium. The culture conditions were optimized in terms of 1) initial cell/microcarrier ratio, 2) 
inoculation method and 3) agitation rate, in the PBS-0.1 vessel using 80 mL working volume. The cells were 
successfully expanded, up to a 7-fold increase in cell number, after 6 days in the bioreactor. Glucose 
consumption and lactate production were analyzed to prevent glucose starvation or excessive lactate 
accumulation. These optimized culture conditions were successfully repeated in a larger vessel, the PBS-0.5 
using 300 mL working volume, demonstrating the scalability of the Vertical-Wheel system. With this PBS-0.5 
bioreactor, 3 x 108 cells were produced after 6 days of operation, and the specific growth rate (0.72 day-1) was 
similar to the one observed with the PBS-0.1 (0.68 day-1). The applications of iPSC cells and their progeny, 
especially in clinical settings, will require a guarantee of cell quality. After PBS-MINI bioreactor culture, the 
expression of pluripotency markers, such as Oct4, Nanog, and SSEA4 was assessed by immunocytochemistry 
and flow cytometry. The directed differentiation into the neural lineage of the expanded cells was performed and 
the pluripotency of the cells was further tested after embryoid body formation. The robustness of this process 
method was evaluated by cultivating another iPSC cell line under the same process conditions, resulting in 
identical growth kinetics in the PBS MINI-0.1. The methodology developed herein, which grows human iPSC on 
microcarriers in single-use bioreactors using chemically defined xeno-free cultivation reagents provides a 
foundation upon which further refinement and scale-up of processes can be built for large scale production of 
iPSCs.   
 
